Chinese Journal of Stroke ›› 2018, Vol. 13 ›› Issue (06): 542-549.DOI: 10.3969/j.issn.1673-5765.2018.06.003
Previous Articles Next Articles
Received:
2018-04-10
Online:
2018-06-20
Published:
2018-06-20
吕微,姜勇,张心邈,荆京,孟霞,周脉耕
通讯作者:
周脉耕 maigengzhou@126.com
基金资助:
国家科技支撑计划项目“中国国家卒中登记研究(CNSR)”课题(2006BA101A11)
国家科技支撑计划项目“重大慢病国家注册登记研究”课题(2015BAI12B02)
LYU Wei, JIANG Yong, ZHANG Xin-Miao, JING Jing, MENG Xia, ZHOU Mai-Geng. Effect of Statin Use During Hospitalization on Short-term Stroke Recurrence in Acute Ischemic Stroke with Chronic Kidney Disease in Chinese Population[J]. Chinese Journal of Stroke, 2018, 13(06): 542-549.
吕微, 姜勇, 张心邈, 荆京, 孟霞, 周脉耕. 住院期间他汀类药物治疗对伴有慢性肾脏病的急性缺血性卒中患者短期卒中复发的影响[J]. 中国卒中杂志, 2018, 13(06): 542-549.
[1] LEE M,SAVER J L,CHANG K H,et al. Lowglomerular filtration rate and risk of stroke:metaanalysis[J/OL]. BMJ,2010,341:4249. https://doi.org/10.1136/bmj.c4249.[2] KIM S J,BANG O Y. Antiplatelet therapy forpreventing stroke in patients with chronic kidneydisease[J/OL]. Contrib Nephrol,2013,179:119-129.https://doi.org/10.1159/000346730.[3] YAHALOM G,SCHWARTZ R,SCHWAMMENTHAL Y,et al. Chronic kidneydisease and clinical outcome in patients with acutestroke[J]. Stroke,2009,40(4):1296-1303.[4] MOSTOFSKY E,WELLENIUS G A,NOHERIAA,et al. Renal function predicts survival in patientswith acute ischemic stroke[J]. Cerebrovasc Dis,2009,28(1):88-94.[5] KERNAN W N,OVBIAGELE B,BLACK H R,etal. Guidelines for the prevention of stroke in patientswith stroke and transient ischemic attack:a guidelinefor healthcare professionals from the American HeartAssociation/American Stroke Association[J]. Stroke,2014,45(7):2160-2236.[6] MESCHIA J F,BUSHNELL C,BODEN-ALBALAB,et al. Guidelines for the primary prevention of stroke:a statement for healthcare professionals fromthe American Heart Association/American StrokeAssociation[J]. Stroke,2014,45(12):3754-3832.[7] HONG K S,LEE J S. Statins in acute ischemicstroke:a systematic review[J]. J Stroke,2015,17(3):282-301.[8] NÍ CHRÓINÍN D,ASPLUND K,ÅSBERG S,etal. Statin therapy and outcome after ischemic stroke:systematic review and meta-analysis of observationalstudies and randomized trials[J]. Stroke,2013,44(2):448-456.[9] SZUMMER K,LUNDMAN P,JACOBSON SH,et al. Association between statin treatment andoutcome in relation to renal function in survivors ofmyocardial infarction[J]. Kidney Int,2011,79(9):997-1004.[10] TONELLI M,MOYÉ L,SACKS F M,etal. Pravastatin for secondary prevention ofcardiovascular events in persons with mild chronicrenal insufficiency[J]. Ann Intern Med,2003,138(2):98-104.[11] KEOUGH-RYAN T M,KIBERD B A,DIPCHANDC S,et al. Outcomes of acute coronary syndromein a large Canadian cohort:impact of chronic renalinsufficiency,cardiac interventions,and anemia[J].Am J Kidney Dis,2005,46(5):845-855.[12] HOU W,LV J,PERKOVIC V,et al. Effect of statintherapy on cardiovascular and renal outcomes inpatients with chronic kidney disease:a systematicreview and meta-analysis[J]. Eur Heart J,2013,34(24):1807-1817.[13] Cholesterol Treatment Trialists(' CTT)Collaboration,HERRINGTON W G,EMBERSON J,et al. Impactof renal function on the effects of LDL cholesterollowering with statin-based regimens:a meta-analysisof individual participant data from 28 randomisedtrials[J]. Lancet Diabetes Endocrinol,2016,4(10):829-839.[14] TONELLI M,ISLES C,CURHAN G C,et al.Effect of pravastatin on cardiovascular events inpeople with chronic kidney disease[J]. Circulation,2004,110(12):1557-1563.[15] SHEPHERD J,KASTELEIN J J,BITTNER V,et al.Intensive lipid lowering with atorvastatin in patientswith coronary heart disease and chronic kidneydisease:the TNT(Treating to New Targets)study[J].J Am Coll Cardiol,2008,51(15):1448-1454.[16] AMARENCO P,CALLAHAN A 3RD,CAMPESEV M,et al. Effect of high-dose atorvastatin on renalfunction in subjects with stroke or transient ischemicattack in the SPARCL trial[J]. Stroke,2014,45(10):2974-2982.[17] WANG Y,CUI L,JI X,et al. The ChinaNational Stroke Registry for patients with acutecerebrovascular events:design,rationale,andbaseline patient characteristics[J]. Int J Stroke,2011,6(4):355-361.[18] WHO Task Force on Stroke and OtherCerebrovascular Disorders. Stroke--1989.Recommendations on stroke prevention,diagnosis,and therapy. Report of the WHO Task Force onStroke and other Cerebrovascular Disorders[J].Stroke,1989,20(10):1407-1431.[19] SONG B,WANG Y,ZHAO X,et al. Associationbetween statin use and short-term outcome basedon severity of ischemic stroke:a cohort study[J/OL]. PLoS One,2014,9(1):e84389. https://doi.org/10.1371/journal.pone.0084389.[20] PAN Y,SONG T,CHEN R,et al. Socioeconomicdeprivation and mortality in people after ischemicstroke:the China National Stroke Registry[J]. Int JStroke,2016,11(5):557-564.[21] ADAMS H P JR,BENDIXEN B H,KAPPELLE LJ,et al. Classification of subtype of acute ischemicstroke. Definitions for use in a multicenter clinicaltrial. TOAST. Trial of Org 10172 in Acute StrokeTreatment[J]. Stroke,1993,24(1):35-41.[22] WANG Y,XU J,ZHAO X,et al. Association ofhypertension with stroke recurrence depends onischemic stroke subtype[J]. Stroke,2013,44(5):1232-1237.[23] TEO B W,XU H,WANG D,et al. GFR estimatingequations in a multiethnic Asian population[J]. Am JKidney Dis,2011,58(1):56-63.[24] ZHOU Y,PAN Y,WU Y,et al. Effect of estimatedglomerular filtration rate decline on the efficacy andsafety of clopidogrel with aspirin in minor strokeor transient ischemic attack:CHANCE Substudy(Clopidogrel in High-Risk Patients With AcuteNondisabling Cerebrovascular Events)[J]. Stroke,2016,47(11):2791-2796.[25] LUO Y,WANG X,WANG Y,et al. Association ofglomerular filtration rate with outcomes of acutestroke in type 2 diabetic patients:results from theChina National Stroke Registry[J]. Diabetes Care,2014,37(1):173-179.[26] LUO Y,WANG X,MATSUSHITA K,et al.Associations between estimated glomerularfiltration rate and stroke outcomes in diabetic versusnondiabetic patients[J]. Stroke,2014,45(10):2887-2893.[27] LEVEY A S,CORESH J,BALK E,et al. National Kidney Foundation practice guidelines for chronickidney disease:evaluation,classification,andstratification[J]. Ann Intern Med,2003,139(2):137-147.[28] BEST P J,STEINHUBL S R,BERGER P B,et al.The efficacy and safety of short- and long-term dualantiplatelet therapy in patients with mild or moderatechronic kidney disease:results from the Clopidogrelfor the Reduction of Events During Observation(CREDO)trial[J]. Am Heart J,2008,155(4):687-693.[29] CAPPELLARI M,DELUCA C,TINAZZI M,etal. Does statin in the acute phase of ischemic strokeimprove outcome after intravenous thrombolysis? Aretrospective study[J]. J Neurol Sci,2011,308(1-2):128-134.[30] FLINT A C,KAMEL H,NAVI B B,et al. Statinuse during ischemic stroke hospitalization is stronglyassociated with improved poststroke survival[J].Stroke,2012,43(1):147-154.[31] NÍ CHRÓINÍN D,CALLALY E L,DUGGANJ,et al. Association between acute statin therapy,survival,and improved functional outcome afterischemic stroke:the North Dublin Population StrokeStudy[J]. Stroke,2011,42(4):1021-1029.[32] FLINT A C,KAMEL H,NAVI B B,et al. Inpatientstatin use predicts improved ischemic strokedischarge disposition[J]. Neurology,2012,78(21):1678-1683.[33] AL-KHALED M,MATTHIS C,EGGERS J. Statintreatment in patients with acute ischemic stroke[J].Int J Stroke,2014,9(5):597-601.[34] WEEKS D L,GREER C L,WILLSON M N. Statinmedication use and nosocomial infection risk in theacute phase of stroke[J]. J Stroke Cerebrovasc Dis,2016,25(10):2360-2367.[35] TOYODA K,MINEMATSU K,YASAKA M,etal. The Japan Statin Treatment Against RecurrentStroke(J-STARS)Echo Study:Rationale and TrialProtocol[J]. J Stroke Cerebrovasc Dis,2017,26(3):595-599.[36] SONG B,WANG Y,ZHAO X,et al. Inpatient statinuse is associated with decreased mortality of acutestroke patients with very low low-density lipoproteincholesterol[J]. J Stroke Cerebrovasc Dis,2015,24(10):2369-2374.[37] SHIBUI T,NAKAGOMI A,KUSAMA Y,et al.Impact of statin therapy on renal function and longtermprognosis in acute coronary syndrome patientswith chronic kidney disease[J]. Int Heart J,2010,51(5):312-318.[38] LIM S Y,BAE E H,CHOI J S,et al. Effect onshort- and long-term major adverse cardiac eventsof statin treatment in patients with acute myocardialinfarction and renal dysfunction[J]. Am J Cardiol,2012,109(10):1425-1430.[39] ATHYROS V G,KATSIKI N,KARAGIANNIS A,et al. Statins can improve proteinuria and glomerularfiltration rate loss in chronic kidney disease patients,further reducing cardiovascular risk. Fact orfiction?[J]. Expert Opin Pharmacother,2015,16(10):1449-1461.[40] STRIPPOLI G F,NAVANEETHAN S D,JOHNSOND W,et al. Effects of statins in patients with chronickidney disease:meta-analysis and meta-regressionof randomised controlled trials[J]. BMJ,2008,336(7645):645-651.[41] HALCOX J P,DEANFIELD J E. Beyondthe laboratory:clinical implications for statinpleiotropy[J]. Circulation,2004,109(21 Suppl 1):42-48.[42] BARYAN H K,ALLAN S M,VAIL A,et al.Systematic review and meta-analysis of the efficacyof statins in experimental stroke[J]. Int J Stroke,2012,7(2):150-156.[43] CACHOFEIRO V,GOICOCHEA M,DE VINUESAS G,et al. Oxidative stress and inflammation,a linkbetween chronic kidney disease and cardiovasculardisease[J]. Kidney Int Suppl,2008,74(111):4-9. |
[1] | XIANG Wei, XU Luyao, ZHANG Manman, WEI Hongchun, LIANG Zhigang. The Frequency and Influencing Factors of Asymmetrical Prominent Veins Sign on Susceptibility-Weighted Imaging in Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(10): 1097-1102. |
[2] | ZHANG Boyu, GUO Yucheng, CUI Yuxia, LI Yingli, LYU Yumei. Seeking Medical Services Decision-Making Status and Relevant Influencing Factors in Patients with Acute Ischemic Stroke: A Review [J]. Chinese Journal of Stroke, 2022, 17(10): 1127-1132. |
[3] | WU Tingting, LIU Yafei, YAN Shixi, WU Yiping, ZHANG Zhongbo, ZAHNG Hanfei, FANG Pinping. Application of “Internet Plus” in Emergency Care of Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(10): 1133-1138. |
[4] | ZHENG Wei, ZHAI Huazheng, CHEN Mengmeng, WANG Jingye. Efficacy and Safety of Direct Thrombectomy versus Bridging Therapy for Acute Ischemic Stroke: A Meta-Analysis [J]. Chinese Journal of Stroke, 2022, 17(07): 720-729. |
[5] | ZHOU Juan, TAN Yunbin, WANG Tiejun, SHI Fuming, YU Ping. Incidence and Influencing Factors of Anxiety and Depression in Caregivers of Patients with Acute Ischemic Stroke during Hospitalization [J]. Chinese Journal of Stroke, 2022, 17(07): 764-768. |
[6] | XUAN Guiying, FAN Caili, XUAN Lixia, ZHAO Qianqian, LI Xuemei. Analysis of Reasons for Loss of Follow-up among Acute Ischemic Stroke Patients during the COVID-19 Pandemic [J]. Chinese Journal of Stroke, 2022, 17(06): 648-652. |
[7] | ZHANG Dong, LI Zhizhang, MA Ruinan, YUE Yunhua. Correlation between Stress Hyperglycemia Ratio and Clinical Prognosis of Patients with Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(05): 483-490. |
[8] | HUANG Yan, FU Xuejun, SHI Huijie, ZOU Liangyu. Correlation between Triglyceride-Glucose Index and Neurological Function Impairment after Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(03): 251-257. |
[9] | CAO Shuang, ZHAO Lu, PEI Lulu, YANG Shuxiang, GAO Yuan, FANG Hui, SUN Shilei, WU Jun, SONG Bo, XU Yuming. The Predictive Value of Neuroimaging-based Risk Evaluation Model on the Prognosis of Cerebral Infarction Patients with Transient Symptoms [J]. Chinese Journal of Stroke, 2022, 17(03): 278-284. |
[10] | LIU Zhong, LIU Yuanyuan, XU Shaofeng, GUO Wei, KANG Hai. Correlation Analysis of Systemic Immune-Inflammatory Index with Severity and Prognosis of Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(03): 285-291. |
[11] | GUO Songtao, E Bu, LI Zhiqiang, JIANG Hao, XU Yuzhu, SUN Jian, SHI Jianmin, WU Xi, GUO Wei. Advances in the Application of 5G Mobile Stroke Unit [J]. Chinese Journal of Stroke, 2022, 17(02): 113-117. |
[12] | HUO Xiaochuan, LI Xiaoqing, MIAO Zhongrong, Expert Committee for Neurointervention Quality Control of National Center for Healthcare Quality Management in Neurological Diseases, Endovascular Treatment Working Committee of National Action for Quality Improvement of Acute Cerebral Infarction Reperfusion Therapy. A Survey of Current Practice in Acute Ischemic Stroke Endovascular Treatment in China in 2020 [J]. Chinese Journal of Stroke, 2022, 17(01): 56-65. |
[13] | CHENG Si, XU Qin, XU Zhe, SHI Yanfeng, LIU Yang, LI Zixiao, MENG Xia, LI Hao, WANG Yongjun. Effect of Prior Stroke on Stroke Outcomes in Patients with Ischemic Cerebrovascular Disease [J]. Chinese Journal of Stroke, 2021, 16(12): 1242-1247. |
[14] | CHEN Zhengyu, CHEN Guofang, CHEN Tong, MA Dongjiao. Influencing Factors of Leukoaraiosis at Different Brain Regions in Patients with Intravenous Thrombolysis for Acute Ischemic Strok [J]. Chinese Journal of Stroke, 2021, 16(12): 1248-1252. |
[15] | LU Qing-Li, WANG Jing, LIU Zhong-Zhong, LIU Pei, LIU Yan, CHANG Qiao-Qiao, LIN Xue-Mei, SHI Ya-Ling, WANG Fang, WU Song-Di. Clinical Characteristics and 1-Year Prognosis of First-ever Cerebral Infarction Patients with Atrial Fibrillation in Xi'an [J]. Chinese Journal of Stroke, 2021, 16(11): 1131-1136. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||